SCHEMBL29975518

SCHEMBL29975518

CSc1ncnc2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
HTT P42858 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
CYP1A2 P05177 1/20 0.55
CYP2C19 P33261 1/20 0.55
MAPT P10636 7/20 0.54
LMNA P02545 4/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
KMT2A Q03164 3/20 0.54
MEN1 O00255 2/20 0.54
KDM1A O60341 1/20 0.53
BCAT2 O15382 1/20 0.51
L3MBTL1 Q9Y468 3/20 0.50
PKM P14618 1/20 0.50
PI4KA P42356 1/20 0.50
PI4K2B Q8TCG2 1/20 0.50
PI4K2A Q9BTU6 1/20 0.50
PI4KB Q9UBF8 1/20 0.50
PDE4A P27815 1/20 0.50
PDE4B Q07343 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1780458 1.00 ALDH1A1 (0.56) ALDH1A1HTTTDP1CYP1A2CYP2C19
SCHEMBL11803328 0.83 HTT (0.59) ALDH1A1HTTTDP1MAPTLMNA
SCHEMBL27212829 0.76 KDM1A (0.58) ALDH1A1HTTTDP1MAPTLMNA
SCHEMBL11807293 0.76 MAPT (0.65) ALDH1A1HTTTDP1MAPTLMNA
SCHEMBL5269788 0.76 BCAT2 (0.60) ALDH1A1HTTTDP1CYP1A2CYP2C19
SCHEMBL6833209 0.75 EGFR (0.42) ALDH1A1HTTTDP1CYP1A2CYP2C19
SCHEMBL6837647 0.75 EGFR (0.42) EGFRRAB9A
SCHEMBL6213388 0.74 MAPT (0.61) ALDH1A1HTTTDP1MAPTLMNA
SCHEMBL5136561 0.73 ALDH1A1 (0.58) ALDH1A1HTTTDP1MAPTLMNA
SCHEMBL5136559 0.73 BCAT2 (0.57) ALDH1A1HTTTDP1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118974055-A Quinazoline compounds as inhibitors of mutant KRAS proteins and uses thereof 美国安进公司 2024-11-15 CN disclosed
EP-4329757-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2024-03-06 EP disclosed
CN-117561063-A Heterocyclic compounds and methods of use 安进公司 2024-02-13 CN disclosed
WO-2022232331-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2022-11-03 WO disclosed